Stocks Near Their 52-Week High — Financial View · Biological Products, (No Diagnostic Substances)
31 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — momentum/breakout candidates, largest first. Financial columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–31 of 31
| AMGN | Amgen | $240.1B | 2.2% | 9.1% | 74.8% | 12.7% | 1.37 | 4.90 | 69.5% | 30.0% | 23.0% | 444.20 | +0.31% | 69K |
| GILD | Gilead Sciences | $187.5B | 2.1% | -6.6% | -27.4% | -8.5% | 1.27 | 2.22 | 79.6% | -8.2% | -10.6% | 151.21 | +1.09% | 186K |
| RVMD | Revolution Medicines, Inc. | $45.2B | — | -40.9% | -67.8% | -67.8% | 11.38 | 0.66 | — | — | — | 210.79 | +0.76% | 72K |
| BIIB | Biogen | $33.1B | — | 4.7% | 7.4% | 5.5% | 3.06 | 0.34 | 75.5% | 28.6% | 13.8% | 224.49 | +0.78% | 32K |
| EXEL | Exelixis, Inc. | $14.7B | — | 34.5% | 46.7% | 46.7% | 3.46 | 0.00 | 96.5% | 39.9% | 35.3% | 59.13 | +1.00% | 116K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | — | 16.0% | — | 19.9% | 2.71 | 13.50 | 82.4% | 35.9% | 24.9% | 110.73 | +1.01% | 90K |
| TECH | Bio-Techne | $11.4B | 0.4% | 7.0% | 8.6% | 8.6% | 4.55 | — | 65.8% | 20.7% | 15.0% | 72.46 | +0.21% | 124K |
| KRYS | Krystal Biotech, Inc. | $11.0B | — | 16.1% | 17.8% | 17.7% | 8.32 | 0.00 | — | 44.9% | 54.8% | 371.35 | +0.58% | 14K |
| APGE | Apogee Therapeutics, Inc. | $10.2B | — | -22.0% | — | — | 26.44 | — | — | — | — | 135.08 | +0.04% | 89K |
| KYMR | Kymera Therapeutics, Inc. | $9.7B | — | -18.2% | -19.9% | -19.9% | 10.34 | 0.09 | 0.0% | — | — | 117.15 | -1.24% | 40K |
| PCVX | Vaxcyte, Inc. | $9.1B | 0.0% | -33.9% | -38.6% | -38.6% | 5.72 | 0.14 | — | — | — | 61.22 | -0.62% | 43K |
| SRRK | Scholar Rock Holding Corp | $6.8B | — | -78.0% | — | -90.8% | 7.02 | 0.77 | — | — | — | 55.91 | -0.42% | 48K |
| CGON | Cg Oncology, Inc. | $6.6B | — | -20.7% | -21.8% | -21.7% | 22.22 | 0.00 | — | — | — | 74.31 | -0.41% | 31K |
| IOVA | Iovance Biotherapeutics, Inc. | $4.0B | — | -31.6% | -39.3% | -39.3% | 4.35 | 0.24 | 48.4% | -92.7% | -89.1% | 8.80 | +2.09% | 641K |
| ADPT | Adaptive Biotechnologies Corp | $3.9B | — | -10.0% | -44.7% | -44.7% | 4.79 | 0.00 | 75.6% | -12.2% | -20.7% | 24.57 | -0.34% | 108K |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.6B | 0.0% | -7.6% | -13.4% | -11.1% | 3.20 | 0.21 | — | -8.0% | -7.7% | 83.12 | +0.41% | 43K |
| BCRX | Biocryst Pharmaceuticals Inc | $2.6B | — | -69.0% | — | — | 2.32 | -0.87 | 97.8% | -33.3% | -40.9% | 10.10 | -0.79% | 151K |
| REPL | Replimune Group, Inc. | $1.4B | — | — | — | — | 5.23 | 0.80 | — | — | — | 15.28 | -4.32% | 50K |
| CGEM | Cullinan Therapeutics, Inc. | $1.4B | — | -56.3% | -63.6% | -63.6% | 8.42 | 0.13 | — | — | — | 22.16 | -0.81% | 19K |
| ODTX | Odyssey Therapeutics, Inc. | $1.3B | — | — | — | — | 11.36 | 0.15 | — | — | — | 26.38 | -0.90% | 11K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | — | 9.39 | -0.11 | — | — | — | 25.33 | +3.56% | 23K |
| SLDB | Solid Biosciences Inc. | $1.1B | — | -49.2% | -55.4% | -55.4% | 13.82 | 0.12 | — | — | — | 10.42 | +1.36% | 71K |
| CADL | Candel Therapeutics, Inc. | $992M | — | -42.5% | -70.2% | -69.2% | 16.09 | 0.01 | — | — | — | 12.96 | -1.67% | 30K |
| AGEN | AGENUS INC | $371M | — | 53.2% | — | — | 0.34 | -0.15 | 99.5% | 27.3% | 69.3% | 8.23 | +1.86% | 37K |
| IKT | Inhibikase Therapeutics, Inc. | $350M | — | -37.1% | -39.5% | -39.4% | 15.82 | 0.00 | — | — | — | 2.51 | +0.40% | 46K |
| ACOG | Alpha Cognition Inc. | $200M | — | -36.3% | -44.3% | -44.3% | 9.03 | 0.22 | — | — | — | 9.20 | -1.23% | 4K |
| INMB | Inmune Bio, Inc. | $63M | — | -68.6% | -90.4% | — | 4.04 | 0.74 | — | — | — | 2.28 | -3.39% | 9K |
| CRDL | Cardiol Therapeutics Inc. | — | — | — | — | — | — | — | — | — | — | 2.15 | -0.23% | 66K |
| ARGX | Argenx Se | — | — | — | — | — | — | — | — | — | — | 1053.32 | -0.21% | 8K |
| IMCR | Immunocore Holdings Plc | — | — | -1.6% | -4.3% | -2.1% | 4.47 | 1.05 | 98.9% | -5.2% | -4.2% | 37.64 | +0.90% | 16K |
| FENC | FENNEC PHARMACEUTICALS INC. | — | — | -4.3% | -7.7% | -5.3% | 5.85 | 0.46 | 33.8% | -1.9% | -5.5% | 12.54 | +1.70% | 9K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.